Log In
BCIQ
Print this Print this
 

Lamisil, terbinafine hydrochloride

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionAntifungal
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationFungal infection
Indication DetailsTreat tinea capitis
Regulatory Designation
PartnerChina Medical System Holdings Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/17/2014

Undisclosed

Undisclosed

Undisclosed

12/17/2014

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today